CRP and inflammatory bowel disease: In IBD patients, Marlow et al. showed a non-significant reduction of CRP after six weeks and a shift towards a more beneficial microbiota by increasing the relative abundances of butyrate-producing Clostridium coccoides (+2.01%) and Clostridium leptum (+2.66%) groups and decreasing Proteobacteria (−0.45%) [56].